Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7498 p457-464
19 April 2008

This section
Reprint   Photocopy

PDF 240K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events

Pages: 457   458   459   460   461   462   463   464 

457 EC plan to relax patient information rules opposed Pharmaceutical companies will be allowed to publicise information about prescription-only medicines in radio and TV programmes if proposals being drawn up by the EC are approved
PJ 2008;280:457
Full Text

457 Boots lines up more GP services as second in-store surgery opens its doors to patients Boots is developing plans to include more GP services in its stores. The Journal has learnt that the company has a number of projects in the pipeline, including planned in-store GP surgeries in Brighton and Birmingham
PJ 2008;280:457
Full Text

457 NHS Alliance wants GPs to reclaim out-of-hours care GPs should reclaim commissioning responsibility for out-of-hours care — even if they no longer provide the service — in order to maximise continuity of care to patients, according to NHS Alliance
PJ 2008;280:457
Full Text



458 Serious failings identified by HM Chief Inspector of Prisons at private prison pharmacy in Wales Prison inspectors discovered serious failings in the management of pharmacy services at a privately run training prison for young offenders in Wales following an unannounced inspection, according to their report published this week
PJ 2008;280:458
Full Text

458 New staff safety and security campaign launched in Kent A campaign to reduce the abuse of NHS staff has been launched in Kent following an analysis of statistics that reveals that 1,870 staff members in the region have been physically assaulted by patients over the past three years
PJ 2008;280:458
Full Text

458 Roadshows planned in Scotland to debate future leadership Roadshows designed to engage pharmacists across Scotland in the debate over the future professional leadership body are being organised by the Royal Pharmaceutical Society’s Scottish Pharmacy Board
PJ 2008;280:458
Full Text

458 Early halting of clinical trials for new cancer treatments cuts patient safety data Clinical trials of new cancer medicines are increasingly likely to be stopped early because new treatments provide statistically significant benefits to patients and this is reducing the amount of safety data available before drugs are launched, Italian and Dutch researchers have warned in a study published online
PJ 2008;280:458
Full Text



459 Switching trimethoprim will not lead to increased resistance Changing the status of a prescription-only antibiotic for the treatment of cystitis to an over-the-counter medicine will not lead to an increase in antibiotic resistance, according to the National Pharmacy Association
PJ 2008;280:459
Full Text

459 Loop diuretics associated with hip bone loss Older men who take loop diuretics appear to have increased rates of hip bone loss than men who are not taking these medicines
PJ 2008;280:459
Full Text

459 Small benefit for antibiotics in sinusitis but consider risks Antibiotics provide a small benefit in acute sinusitis, but this must be weighed against potential adverse effects for individuals and the population as a whole, the authors of a Cochrane review conclude
PJ 2008;280:459
Full Text

459 Chris Morris withdraws from English board election Chris Morris, a member of the Royal Pharmaceutical Society’s English Pharmacy Board, has withdrawn from the forthcoming board elections
PJ 2008;280:459
Full Text



460 Vildagliptin and nelarabine given green light for use in NHS Scotland Vildagliptin and nelarabine are among drugs accepted for use by NHS Scotland by the Scottish Medicines Consortium this month
PJ 2008;280:460
Full Text

460 DTB reviews glitazones There is no convincing evidence that glitazones offer clinical benefit over metformin or sulphonylureas when used as monotherapy in type 2 diabetes, the Drug and Therapeutics Bulletin has concluded
PJ 2008;280:460
Full Text

460 MPs lobbied to push pharmacy up Scottish political agenda Pharmacists in Scotland have begun lobbying politicians as part of a new effort to push pharmacy higher up the political agenda
PJ 2008;280:460
Full Text

460 Medical journals should require all authors to report their contributions Medical journals should require all authors to report their specific contributions to an article submitted for publication and should consider publishing these contributions, according to an editorial published this week
PJ 2008;280:460
Full Text

460 Joint working in Scotland The Care Commission and the Royal Pharmaceutical Society have agreed to work together closely on the safe management of medicines in Scotland
PJ 2008;280:460
Full Text

460 UniChem buys Central Homecare Pharmaceutical wholesaler UniChem has acquired Central Homecare — a provider of services for home administration of specialist medicines
PJ 2008;280:460
Full Text



461 Setback for GSK over drug distribution in Greece GlaxoSmithKline has been dealt a blow in its long-running battle over the distribution of its drugs in Greece following EU legal opinion published earlier this month
PJ 2008;280:461
Full Text

461 Industry pessimistic about future of research and development in UK Pharmaceutical companies are pessimistic about the industry’s future in the UK, a survey has revealed
PJ 2008;280:461
Full Text

461 National hay fever campaign launched TV presenter Melinda Messenger joined Welsh Pharmacy Board member Marc Donovan earlier this week to support a national hay fever campaign launched by the Royal Pharmaceutical Society
PJ 2008;280:461
Full Text

461 Pharmacy debate pack A new resource — Pharmacy Debate Pack — designed to encourage secondary school pupils to debate topical health issues and to forge contacts with local pharmacists has been developed by the Royal Pharmaceutical Society’s museum
PJ 2008;280:461
Full Text

461 Singulair and suicidal behaviour A possible association between the use of montelukast (Singulair) and suicidal thinking and behaviour is being investigated by the US Food and Drug Administration
PJ 2008;280:461
Full Text



462 Prasugrel cuts ischaemic events with stents more than clopidogrel Intensive therapy with a new antiplatelet agent — prasugrel — results in fewer ischaemic events than with clopidogrel in patients with intracoronary stents, irrespective of the type of stent used, according to a study published online
PJ 2008;280:462
Full Text

462 Weekly paclitaxel raises breast cancer survival Weekly administration of paclitaxel, following adjuvant therapy with doxorubicin and cyclophosphamide, improves survival in women with breast cancer, compared with a standard three-weekly regimen, new research shows
PJ 2008;280:462
Full Text

462 Preventing sickle-cell complications Experiments in mice suggest that an endothelin receptor antagonist could help prevent the life-threatening complications of sickle-cell disease
PJ 2008;280:462
Full Text

462 Hypereosinophilic treatment Mepolizumab, a monoclonal antibody, may be able to treat the underlying cause of hypereosinophilic syndrome
PJ 2008;280:462
Full Text

462 Healing spinal injuries Peptide amphiphile molecules that self-assemble into nanoscale fibres have been used to treat spinal cord injuries in mice
PJ 2008;280:462
Full Text

462 Three-year benefit in MS Fingolimod, a novel immunomodulating agent, can maintain low relapse rates for three years in multiple sclerosis patients, results presented at the American Academy of Neurology annual meeting in Chicago, Illinois, this week suggest
PJ 2008;280:462
Full Text



463 Role in tackling health inequalities put to MPs Primary care trusts are ignoring the potential of community pharmacy in helping eradicate health inequality, the Royal Pharmaceutical Society has told an influential committee of MPs
PJ 2008;280:463
Full Text

463 Polyclinic plan is misguided says Society in London review response The Government’s hope that a network of super surgeries or polyclinics in London will improve access to healthcare is misguided, according to the Royal Pharmaceutical Society
PJ 2008;280:463
Full Text

463 PDA Union inaugurated and applies for Government listing The Pharmacists’ Defence Association Union has formally applied for listing to the Government Trades Union Certification Officer following the inaugural meetings of its five membership groups and the formation of its full executive committee
PJ 2008;280:463
Full Text

463 DoH must improve handling of information requests The Information Commissioner’s Office has declared that the Department of Health must improve the way it handles requests under the Freedom of Information Act
PJ 2008;280:463
Full Text



464 Antidepressants might contribute less than thought to suicide rate Antidepressants may be contributing less to the prevention of suicide than previously believed, according to the results of a joint US/Danish study published this week
PJ 2008;280:464
Full Text

464 Treatment with statins leads to modest reduction in BP Use of statins in individuals with no known cardiovascular disease or diabetes results in a modest, but significant, reduction in blood pressure, a new study suggests
PJ 2008;280:464
Full Text

Back to Top


©The Pharmaceutical Journal